R01 CA255021/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2021	1
2023	1
2024	1

Page 1

EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer.

Tan X, Xiao GY, Wang S, Shi L, Zhao Y, Liu X, Yu J, Russell WK, Creighton CJ, Kurie JM. Tan X, et al. J Clin Invest. 2023 Apr 3;133(7):e165863. doi: 10.1172/JCI165863. J Clin Invest. 2023. PMID: 36757799 Free PMC article.

Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancer.

Tan X, Wang S, Xiao GY, Wu C, Liu X, Zhou B, Yu J, Duose DY, Xi Y, Wang J, Gupta K, Pataer A, Roth JA, Kim MP, Chen F, Creighton CJ, Russell WK, Kurie JM. Tan X, et al. J Clin Invest. 2024 Apr 25;134(12):e176355. doi: 10.1172/JCI176355. Online ahead of print. J Clin Invest. 2024. PMID: 38662435 Free PMC article.

A protumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma.

Tan X, Shi L, Banerjee P, Liu X, Guo HF, Yu J, Bota-Rabassedas N, Rodriguez BL, Gibbons DL, Russell WK, Creighton CJ, Kurie JM. Tan X, et al. J Clin Invest. 2021 Jan 4;131(1):e137186. doi: 10.1172/JCI137186. J Clin Invest. 2021. PMID: 32931483 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year